As of 2026-04-02, the Intrinsic Value of Prism Medico and Pharmacy Ltd (512217.BO) is 0.83 INR. This 512217.BO valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 26.40 INR, the upside of Prism Medico and Pharmacy Ltd is -96.90%.
The range of the Intrinsic Value is 0.80 - 0.87 INR
Based on its market price of 26.40 INR and our intrinsic valuation, Prism Medico and Pharmacy Ltd (512217.BO) is overvalued by 96.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (4.37) - (1.45) | (2.36) | -108.9% |
| DCF (Growth 10y) | (2.39) - (6.10) | (3.55) | -113.5% |
| DCF (EBITDA 5y) | 0.80 - 0.87 | 0.83 | -96.9% |
| DCF (EBITDA 10y) | 0.24 - 0.35 | 0.28 | -98.9% |
| Fair Value | 4.83 - 4.83 | 4.83 | -81.72% |
| P/E | 6.87 - 13.05 | 7.48 | -71.7% |
| EV/EBITDA | 2.92 - 14.29 | 5.86 | -77.8% |
| EPV | 3.42 - 3.99 | 3.71 | -86.0% |
| DDM - Stable | 7.00 - 17.37 | 12.18 | -53.8% |
| DDM - Multi | 0.17 - 0.32 | 0.22 | -99.2% |
| Market Cap (mil) | 159.98 |
| Beta | 0.26 |
| Outstanding shares (mil) | 6.06 |
| Enterprise Value (mil) | 159.33 |
| Market risk premium | 8.31% |
| Cost of Equity | 11.33% |
| Cost of Debt | 7.46% |
| WACC | 8.43% |